ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Palmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline Operations

BOWIE, Md., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced Palmetto Pharm, a patient-focused, pharmacist-owned independent specialty pharmacy, selected Inovalon's ScriptMed® Specialty as their pharmacy management software. Inovalon’s ScriptMed Specialty will equip Palmetto Pharm with actionable insights to reduce administrative burden, foster improved collaboration between patients, providers, and health plans, and accelerate the time to therapies for enhanced clinical and financial outcomes.

Founded in 2022, Palmetto Pharm required a best-in-class cloud-based platform to scale efficiently and achieve its goal of becoming a nationwide specialty pharmacy licensed in all 50 states. With their selection of the Inovalon pharmacy software platform solution, ScriptMed Specialty will now serve as the foundation for Palmetto Pharm’s customer-centric approach, which enables providers and patients to focus on managing their care for optimal outcomes. Additionally, ScriptMed will aid Palmetto Pharm with end-to-end prescription management, maintaining compliance with industry standards, and providing the highest level of care while ensuring to meet the requirements of the URAC and ACHC Specialty Pharmacy Accreditation.

"Palmetto Pharm pursued a technology partner that could accelerate our ability to scale and help us fulfill our mission of delivering patient-centric care and a seamless experience for providers and patients," said Ryan Fennick, Founder and Chief Executive Officer of Palmetto Pharm. "ScriptMed Specialty software met both our clinical and operational needs and gives us the technological harness to provide value to our customers with an end-to-end solution. The partnership with Inovalon enabled us to follow through with Palmetto’s mission of Use as Written, ensuring products prescribed by healthcare providers are the products that make it to our customers’ door, wherever they live in the US.”

By partnering with Inovalon, Palmetto Pharm is streamlining and automating operational tasks such as referrals, revenue cycle management, inventory management, and prescription delivery to reduce the time and cost to fill and empower providers to deliver high-quality, patient-centric care. ScriptMed is powered by the Inovalon ONE® Platform and is the only end-to-end, cloud-native solution designed to meet specialty pharmacies' complex operational, financial, and clinical needs.

"Palmetto Pharm is a great example of how an engaged start-up can use cloud-based technology to develop a strong foundation while enabling growth concurrently," said Ernie Shopes, President and General Manager of Inovalon’s Pharmacy Business Unit. "We designed ScriptMed to be an end-to-end, flexible cloud platform that grows with organizations like Palmetto Pharm as they scale to drive workflow efficiencies, personalize care plans, and make data actionable at all points of care for the best outcomes. Adopting best-in-class technology is just one way Palmetto Pharm goes the extra mile for patients and care teams, positioning them for continued success in the fast-growing specialty pharmacy market."

For more information on Inovalon's ScriptMed pharmacy solutions, please click here: https://www.inovalon.com/products/pharmacy-cloud/.

About Inovalon

Inovalon is a leading provider of cloud-based software solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company's analytics and capabilities are used by nearly 20,000 customers supporting over 50,000 sites of care, and are informed by the primary source data of more than 80 billion medical events across 1.1 million physicians, 659,000 clinical settings, and 379 million unique patients. For more information, visit www.inovalon.com.

About Palmetto Specialty Pharm

Palmetto Pharm is a nationwide specialty pharmacy dedicated to delivering a first-class patient experience, while collaborating with patients and providers to enhance access to specialty medications. Our team works in partnership with patients, providers, manufacturers, and payers to alleviate their administrative burdens. We model our core services around what is most important – the people we serve. Our resolute team of trained patient care and clinical specialists, work with the latest HIPAA compliant, cloud-based technology, to provide high-touch customer focused protocols and a secure and streamlined process, while staying true to our motto, "Use as Written.” For more information, visit www.palmettopharm.com.

Contact:
Tom Paolella
Sr. Director, Press and Analyst Relations, Inovalon
Thomas.Paolella@inovalon.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.